CN116194595A - 婴幼儿特应性皮炎的检测方法 - Google Patents

婴幼儿特应性皮炎的检测方法 Download PDF

Info

Publication number
CN116194595A
CN116194595A CN202180063499.9A CN202180063499A CN116194595A CN 116194595 A CN116194595 A CN 116194595A CN 202180063499 A CN202180063499 A CN 202180063499A CN 116194595 A CN116194595 A CN 116194595A
Authority
CN
China
Prior art keywords
atopic dermatitis
gene
infants
tarc
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180063499.9A
Other languages
English (en)
Chinese (zh)
Inventor
志摩恭子
上原裕也
井上高良
高田直人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of CN116194595A publication Critical patent/CN116194595A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/521—Chemokines
    • G01N2333/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202180063499.9A 2020-09-16 2021-09-16 婴幼儿特应性皮炎的检测方法 Pending CN116194595A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020155444 2020-09-16
JP2020-155444 2020-09-16
PCT/JP2021/034174 WO2022059745A1 (ja) 2020-09-16 2021-09-16 乳幼児アトピー性皮膚炎の検出方法

Publications (1)

Publication Number Publication Date
CN116194595A true CN116194595A (zh) 2023-05-30

Family

ID=80776710

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180063499.9A Pending CN116194595A (zh) 2020-09-16 2021-09-16 婴幼儿特应性皮炎的检测方法

Country Status (5)

Country Link
US (1) US20240011093A1 (cg-RX-API-DMAC7.html)
EP (1) EP4215622A4 (cg-RX-API-DMAC7.html)
JP (1) JP7743239B2 (cg-RX-API-DMAC7.html)
CN (1) CN116194595A (cg-RX-API-DMAC7.html)
WO (1) WO2022059745A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115279901A (zh) * 2020-03-11 2022-11-01 花王株式会社 来自皮肤表面脂质的rna的制备方法
WO2024232368A1 (ja) * 2023-05-08 2024-11-14 花王株式会社 アトピー性皮膚炎の重症度の検出方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108699589A (zh) * 2016-07-08 2018-10-23 花王株式会社 核酸样品的制备方法
CN109196358A (zh) * 2016-06-16 2019-01-11 花王株式会社 婴幼儿的皮肤状态的评价方法
US20190145967A1 (en) * 2016-04-28 2019-05-16 Shiseido Company. Ltd. Index of local severity of atopic dermatitis in skin and therapeutic effect thereon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11376261B2 (en) * 2017-12-18 2022-07-05 University Of Cincinnati Methods for diagnosing and managing treatment of atopic dermatitis
JP7431812B2 (ja) * 2018-05-09 2024-02-15 ダームテック,インク. 自己免疫疾患における新規な遺伝子分類とその使用
WO2020091044A1 (ja) * 2018-11-01 2020-05-07 花王株式会社 被験体の皮膚細胞に由来する核酸の調製方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190145967A1 (en) * 2016-04-28 2019-05-16 Shiseido Company. Ltd. Index of local severity of atopic dermatitis in skin and therapeutic effect thereon
CN109196358A (zh) * 2016-06-16 2019-01-11 花王株式会社 婴幼儿的皮肤状态的评价方法
CN108699589A (zh) * 2016-07-08 2018-10-23 花王株式会社 核酸样品的制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EMMA GUTTMAN-YASSKY ET AL.: "Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic Dermatitis", JAMA DERMATOLOGY, vol. 155, no. 12, 9 October 2019 (2019-10-09) *

Also Published As

Publication number Publication date
JP2022049694A (ja) 2022-03-29
EP4215622A4 (en) 2024-11-20
WO2022059745A1 (ja) 2022-03-24
JP7743239B2 (ja) 2025-09-24
US20240011093A1 (en) 2024-01-11
EP4215622A1 (en) 2023-07-26

Similar Documents

Publication Publication Date Title
JP2020162615A (ja) 敗血症の診断
US12110556B2 (en) Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS)
AU2014233262A1 (en) Methods and compositions for assessing renal status using urine cell free DNA
US10793911B2 (en) Host DNA as a biomarker of Crohn's disease
WO2020148590A1 (en) Nourin molecular biomarkers
WO2021221138A1 (ja) アトピー性皮膚炎の検出方法
JP7743239B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
US20190194725A1 (en) Method for detecting active tuberculosis
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7762549B2 (ja) アトピー性皮膚炎の症度変化の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
US20210087634A1 (en) Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna
KR20250166551A (ko) 대장암 진단용 바이오마커 및 이를 포함한 대장암 진단용 조성물
WO2022186296A1 (ja) アトピー性皮膚炎の症度悪化の検出方法
WO2025172242A1 (en) Method of assessing the risk of death of a patient
CN117385034A (zh) 标志物组合在制备预测肝癌患者预后治疗疗效产品中的应用
JP2022134127A (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
JP2023073134A (ja) ホットフラッシュの検出方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination